NCT Number: NCT04004052
Conservative Treatment and Ultrasound Guided Injection for Treatment Meralgia Paresthetica
Meralgia paresthetica (MP) is an entrapment mononeuropathy of the lateral femoral cutaneous nerve (LFCN), where conservative treatment options are not always sufficient.
The aim of this study was to evaluate the efficacy of ultrasound (US) guided lateral femoral cutaneous nerve injection in the management of meralgia paresthetica by comparing with transcutaneous electrical nerve stimulation (TENS) therapy and sham transcutaneous electrical nerve stimulation therapy.
Looking for future studies?
Notify MeKey information
Conditions
Age range
42 year–64 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
In this prospective, randomized, sham-controlled study, fifty four patients (23 female and 31 male, the mean age 53.61±11.99 years) with lateral femoral cutaneous nerve compression with clinical and electrophysiological findings were enrolled. Patients were randomly assigned to three groups: 1) Ultrasound-guided injection group, 2) TENS group, 3) Sham TENS group. The blockage of the lateral femoral cutaneous nerve was performed for therapeutic meralgia paresthetica management in group 1. Ten sessions of conventional TENS were administered to each patient 5 days a week for 2 weeks, for 20 minutes per daily session in Group 2, and sham TENS was applied to group 3 with the same protocol.
Visual Analog Scale (VAS), painDETECT questionnaire (PD-Q), Semmes Weinstein monofilament test (SWMt), Pittsburgh Sleep Quality Index (PSQI) and health-related quality of life (SF 36), at onset (T1), 15 days after treatment (T2) and 1 month after treatment (T3) were used for evaluation.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients diagnosed with LFCN entrapment confirmed by clinical and electrophysiological findings
Exclusion criteria
- Secondary entrapment neuropathy
- Malignancy
- Pregnancy
- Infection in the inguinal region or dermatitis
- Lumbar radiculopathy
- Cardiac pacemakers
- Polyneuropathy
Treatment and study plan
Transcutaneous Electrical Nerve Stimulation (TENS)
OtherSham Transcutaneous Electrical Nerve Stimulation (TENS)
OtherPrimary outcomes
-
Visual Analog Scale
Time frame: 1 months
The VAS was used to record each patient's current level of pain with 0 indicating no pain and 10 indicating the worst pain that the patient had ever experienced. Using a ruler marked in centimeters, the examiner obtained the exact values along a 10-cm VAS line.
-
painDETECT questionnaire
Time frame: 1 months
It consists of seven items evaluating pain qualities, one evaluating the course of pain, and one evaluating pain radiation. Additionally, the questionnaire contains three numerical rating scales (NRSs) of 0-10 for current, worst, and average pain severity. An overall score is generated that summarizes everything but the pain intensity NRS, which ranges between -1 and 38. An overall score of >18 indicates likely Neuropathic pain, 13-18 possible Neuropathic pain, and < 13 unlikely Neuropathic pain.
-
Semmes-Weinstein monofilament test
Time frame: 1 months
Cutaneous pressure threshold was measured by touch test using a device with nylon Semmes-Weinstein monofilaments (SWMt) embedded in a plastic handle. A small pushing force is applied anterolateral femoral skin area for 1-1,5 seconds to push the filaments. A medical staff member presses the filaments at an angle of approximately 90° against the patient's thigh. This test is useful for medical staff because it is simple and easy. The threshold was defined as the lightest filament that the subject responses correctly at least two out of the three trials. The filaments are labeled with a numerical marking, which is a log to the base ten of the force in tenth of milligrams. Applications was made where the most symptoms has been observed in the patient's anterolateral thigh.
Secondary outcomes
-
Short Form (SF-36) Health Questionnaire
Time frame: 1 months
Assessment of health-related quality of life Health status was measured using the 36-Item Short Form (SF-36) Health Survey, version 2 (SF-36v2), which assesses eight different aspects of health. Item scores can be aggregated into physical component (PC) summary and mental component (MC) summary score.
-
Pittsburgh Sleep Quality Index (PSQI)
Time frame: 1 Months
PSQI is a 19-item self-reported instrument designed to measure a person's sleep quality and sleep patterns over 1-month time interval. It consists of seven items evaluating sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction over the last month. The 7 component scores are evaluated between 0 and 3 points. 3 reflects the negative extreme on the Likert Scale. The global score ranges from 0 to 21 points. Higher scores indicate worst sleep quality. A global score of >5 indicates poor sleep quality.
Sponsors and collaborators
Lead sponsor
Fatih Sultan Mehmet Training and Research Hospital
Other
Registry information
Official study title
Conservative Treatment Versus Ultrasound Guided Injection in Management of Meralgia Paresthetica: A Randomized Controlled Trial
Important dates
- Study start
- 2014
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Jul 1, 2019
- Registry last updated
- Feb 20, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Effectiveness of Low-Level Laser Therapy in the Treatment of Meralgia Paresthetica
NCT07335822
Charcot-Marie-Tooth Disease, Congenital Abnormalities
Istanbul, Fatih, Turkey (Türkiye)
View Trial DetailsPulsed Radiofrequency Ablation and Steroid Injections for the Treatment of Meralgia Paresthetica
NCT06683924
Femoral Neuropathy, Meralgia Paresthetica
Ankara, Turkey (Türkiye)
View Trial DetailsDry Needling Versus Cyriax Technique on Pain, Paraesthesia and Functional Disability in Patients With Chronic Low Back Pain
NCT07089472
Chronic Low-back Pain (cLBP), Femoral Neuropathy
Lahore, Pakistan
View Trial DetailsEffects of Lateral Femoral Cutaneous Nerve Mobilization With and Without Muscle Energy Techniques in Pregnant Females
NCT06751147
Femoral Neuropathy, Meralgia Paresthetica
Lahore, Punjab Province, Pakistan
View Trial Details